Adenovirus may cause heart transplant rejection:
This article was originally published in Clinica
Executive Summary
Rejection of heart transplants, at least in children, may be linked to adenoviral infection, a US team has concluded. Researchers from Baylor College of Medicine in Houston, Texas, and other research institutions, report in The New England Journal of Medicine (May 17) that PCR analysis detected viral DNA in endomyocardial biopsy specimens from 34 out of 149 transplant recipients aged up to 18 years. Some 29 (85%) of these patients had an adverse cardiac event within three months of the biopsy, in contrast to only 39 of the 115 (34%) with negative PCR findings. Adenovirus was found three times as often as the next most common virus, enterovirus. The finding suggests that all heart transplant patients should be routinely screened for viral DNA, the researchers say.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.